Back
Paragon 28 Vs. Perspective Therapeutics Industry Stock Comparison
Buy
81
FNA
Paragon 28
Last Price:
10.44
Seasonality Move:
7.65%
Sell
30
CATX
Perspective Therapeutics
Last Price:
2.99
Seasonality Move:
34.33%
Buy
81
Paragon 28 (FNA)
is a Buy
Is Paragon 28 a Buy, Sell or Hold?
- The current Paragon 28 [FNA] share price is $10.35. The Score for FNA is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- FNA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FNA Stock Price Chart
What is Paragon 28's stock price today?
-
The Paragon 28 share price today is $10.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNA is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $6.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
FNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 76.49 | Buy |
| Chaikin Money Flow: | 233426 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.91 - 8.93) | Buy |
| Bollinger Bands (100): | (5.9 - 8.5) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 14.63 | Sell |
| Chaikin Money Flow: | -723713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.98 - 12.88) | Sell |
| Bollinger Bands (100): | (10.81 - 14.53) | Sell |
FNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.52 | Buy |
| 20-day SMA: | 7.29 | Buy |
| 50-day SMA: | 6.64 | Buy |
| 200-day SMA: | 8.45 | Buy |
| 8-day EMA: | 9.5 | Buy |
| 20-day EMA: | 8.06 | Buy |
| 50-day EMA: | 7.21 | Buy |
| 200-day EMA: | 8.44 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.55 | Sell |
| 20-day SMA: | 10.54 | Sell |
| 50-day SMA: | 12.08 | Sell |
| 200-day SMA: | 12.78 | Sell |
| 8-day EMA: | 8.2 | Sell |
| 20-day EMA: | 9.96 | Sell |
| 50-day EMA: | 11.52 | Sell |
| 200-day EMA: | 11.52 | Sell |
Paragon 28 Earnings Growth & FNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.17 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Paragon 28 Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||